Learn About Multiple Sclerosis Treatment Options

Understanding Multiple Sclerosis and Why Treatment Matters

Multiple sclerosis (MS) is a long-term disease that affects the brain and spinal cord. In MS, the immune system mistakenly attacks myelin, which is the protective coating around nerve fibers. This damage slows down or blocks messages between the brain and the rest of the body. The result can be various symptoms, including fatigue, difficulty walking, vision problems, numbness, and weakness.

According to the National Multiple Sclerosis Society, about 1 million people in the United States live with MS. Most people are diagnosed between ages 20 and 50, though MS can develop at any age. The disease progresses differently in each person. Some people have mild symptoms that come and go, while others develop more severe symptoms over time.

Treatment for MS has changed dramatically over the past two decades. Before the 1990s, doctors had very few options to offer patients. Today, there are more than a dozen FDA-approved medications that can slow disease progression, reduce the frequency and severity of attacks, and help manage symptoms. Understanding these treatment options is important because starting treatment earlier in the disease course often leads to better long-term outcomes.

The goals of MS treatment include slowing disease progression, managing current symptoms, preventing new symptoms from developing, and improving quality of life. Different treatments work in different ways, and what works best depends on the type of MS a person has, how active the disease is, their age, other health conditions, and how they tolerate certain medications.

Practical takeaway: Learning about MS treatment options gives you and your healthcare team more information to discuss during appointments. Having knowledge about these options helps you participate in decisions about your care.

Types of Multiple Sclerosis and How They Affect Treatment Choices

Multiple sclerosis has several different patterns of disease activity, and doctors classify these into distinct types. Understanding which type of MS a person has is crucial because it determines which treatments may be recommended.

Relapsing-remitting MS (RRMS) is the most common type, affecting about 85% of people at diagnosis. In this type, people experience periods called relapses or exacerbations when new symptoms appear or existing symptoms worsen. These episodes can last days or weeks. Between relapses, people have periods of partial or complete recovery called remissions, which can last months or years. During remission periods, symptoms may disappear entirely or partially. Many disease-modifying therapies (DMTs) are designed to reduce how often relapses occur and how severe they are.

Secondary progressive MS (SPMS) develops in many people who initially have relapsing-remitting MS. In SPMS, disease progression becomes more steady, with or without relapses. Over time, symptoms gradually worsen, and remissions become less complete. The transition can happen gradually, and some people may not notice a clear shift. Treatment approaches for SPMS differ from RRMS because the focus is on slowing progression rather than primarily reducing relapses.

Primary progressive MS (PPMS) affects about 15% of people at diagnosis. In this type, symptoms gradually worsen from the beginning without distinct relapses and remissions. People experience a steady decline in function over time. Until recently, there were fewer treatment options for PPMS, but newer medications have shown they can slow progression in this type of MS.

Progressive-relapsing MS (PRMS) is the least common type. People with PRMS have worsening symptoms from the start, like primary progressive MS, but they also experience distinct relapses. Treatment decisions for PRMS combine approaches used for both relapsing and progressive forms.

Practical takeaway: Knowing your specific MS type helps you understand why your doctor recommends particular treatments and what outcome measures matter most for monitoring your condition.

Disease-Modifying Therapies: How They Work and Categories of Options

Disease-modifying therapies (DMTs) are medications that directly address the underlying MS process by controlling immune system activity. These drugs can reduce the number and severity of relapses, slow the progression of disability, and reduce the number of new lesions visible on MRI scans. DMTs are different from symptom management medications, which treat specific problems like fatigue or muscle stiffness but don't alter the disease course.

Injectable medications were among the first DMTs developed. Interferon beta medications (such as Avonex, Betaseron, and Rebif) reduce the frequency of relapses by about 30% in people with relapsing-remitting MS. Glatiramer acetate (Copaxone) works differently but achieves similar results. These medications are injected either intramuscularly or subcutaneously, and most people can learn to administer them at home. While effective, injectable medications have fallen out of favor as first-line treatments because newer options are available, though they remain important choices for some individuals.

Oral medications offer an alternative to injections. Medications like fingolimod (Gilenya), dimethyl fumarate (Tecfidera), and teriflunomide (Aubagio) are taken by mouth daily or twice daily. These drugs work through different mechanisms, such as reducing immune cell movement or modulating immune responses. Oral medications tend to have higher relapse reduction rates than injectable drugs, making them popular choices for newly diagnosed patients with relapsing-remitting MS.

Monoclonal antibody infusions represent another category of DMTs. These medications are given intravenously or by injection and include drugs like natalizumab (Tysabri), alemtuzumab (Lemtrada), and ocrelizumab (Ocrevus). These highly effective treatments work by targeting specific immune cells or their interactions. They typically require infusions at a treatment center, though some newer formulations can be administered at home. Monoclonal antibodies generally have higher efficacy rates than injectable or oral medications but may have different side effect profiles.

Choosing among DMT categories involves considering disease activity, how quickly the disease is progressing, personal preferences regarding administration method, potential side effects, and other medical conditions. A person with very active RRMS might benefit from a more potent monoclonal antibody, while someone with mild disease might do well on an oral medication. Your healthcare team can discuss which category may be most appropriate for your situation.

Practical takeaway: Understanding the main categories of DMTs—injectables, oral medications, and infusions—helps you have informed conversations with your doctor about administration methods and efficacy profiles that matter to you.

Managing Symptoms and Complementary Approaches to Treatment

While disease-modifying therapies address the underlying disease process, symptom management medications address specific problems that MS causes. Many people with MS benefit from a combination of DMTs and symptom management strategies. Common MS symptoms and their treatment approaches include the following.

Fatigue affects about 80% of people with MS and often feels more disabling than other symptoms. Medications like amantadine or modafinil may provide some relief, though their effectiveness varies. Non-medication approaches like energy conservation techniques, scheduled rest periods, exercise programs, and addressing sleep problems often help significantly. Speaking with occupational therapists can provide practical strategies for managing daily energy levels.

Muscle stiffness and spasticity occur when muscles become tight and resistant to movement. Baclofen, tizanidine, and dantrolene are medications used to reduce spasticity. Physical therapy, stretching, and heat therapy also help. Some people benefit from more intensive interventions like botulinum toxin injections. Consistent movement and exercise can prevent spasticity from worsening.

Vision problems, including blurred or double vision, can result from optic neuritis or other MS-related issues. While some vision problems resolve on their own, high-dose corticosteroids are sometimes used to speed recovery from optic neuritis. Vision therapy and adaptive devices may help people adjust to vision changes. Some vision problems improve naturally as inflammation decreases with DMT treatment.

Pain occurs in about 50% of people with MS and can include nerve pain, muscle pain, and headaches. Treatment might include pain medications, anti-seizure drugs (which can help with nerve pain), or approaches like physical therapy and acupuncture. Managing pain effectively improves quality of life and participation in rehabilitation activities.

Bladder and bowel problems require careful management because untreated issues can lead to complications. Treatment might include medications